journal
MENU ▼
Read by QxMD icon Read
search

Dermatology and Therapy

journal
https://www.readbyqxmd.com/read/30415373/a-case-of-acute-pemphigus-vulgaris-relapses-associated-with-cocaine-use-and-review-of-the-literature
#1
Omar Jiménez-Zarazúa, Andrés Guzmán-Ramírez, Lourdes N Vélez-Ramírez, Jesús A López-García, Leticia Casimiro-Guzmán, Jaime D Mondragón
Pemphigus is a bullous autoimmune disease that affects the skin and mucous membranes. It is very difficult to establish the etiology and the triggering factors that influence reactivations in pemphigus vulgaris (PV). The case of a 33-year-old male with chronic history of intranasal cocaine consumption is presented in this report. We present the clinical case of the patient, followed for a total of 86 weeks, with ten relapses secondary to probable cocaine use. The patient was admitted to the emergency department after presenting polymorphic dermatosis characterized by blisters, vesicles, and excoriations extending from the oral cavity to the thorax, and to the inguinal and genital regions, affecting approximately 35 % of the body surface area with a score of 56 on the Pemphigus Skin Disorder Index...
November 10, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30392030/scoping-review-on-use-of-drugs-targeting-interleukin-1-pathway-in-dira-and-ditra
#2
REVIEW
Francisco Gómez-García, Juan L Sanz-Cabanillas, Isabel Viguera-Guerra, Beatriz Isla-Tejera, Antonio Vélez-García Nieto, Juan Ruano
INTRODUCTION: Deficiencies in interleukin (IL)-1 receptor (IL-R) antagonist (DIRA) and IL-36R antagonist (DITRA) are rare genetic autoinflammatory diseases related to alterations in antagonists of the IL-1 pathway. IL-1 antagonists may represent therapeutic alternatives. Here, we aim to provide a scoping review of knowledge on use of IL-1-targeting drugs in DIRA and DITRA. METHODS: An a priori protocol was published, and the study was conducted using the methodology described in the Joanna Briggs Institute Reviewer's Manual and the recently published PRISMA Extension for Scoping Review statement...
November 3, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30345457/crisaborole-ointment-improves-quality-of-life-of-patients-with-mild-to-moderate-atopic-dermatitis-and-their-families
#3
Eric L Simpson, Amy S Paller, Mark Boguniewicz, Lawrence F Eichenfield, Steven R Feldman, Jonathan I Silverberg, Sarah L Chamlin, Lee T Zane
INTRODUCTION: The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of life (QoL) was assessed in two identically designed phase 3 studies (AD-301: NCT02118766; AD-302: NCT02118792, both at http://www.clinicaltrials.gov ). METHODS: In both studies, patients aged ≥ 2 years with mild to moderate AD per the Investigator's Static Global Assessment were randomly assigned 2:1 to receive crisaborole or vehicle twice daily for 28 days...
October 22, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30343350/clinical-and-genetic-risk-factors-associated-with-psoriatic-arthritis-among-patients-with-psoriasis
#4
Di Yan, Richard Ahn, Stephen Leslie, Wilson Liao
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that affects an estimated 30% of patients with psoriasis. PsA is underdiagnosed in primary care and dermatology clinics due to a variety of reasons, including failure of healthcare providers to ask about symptoms, overlap of symptoms and signs with other rheumatologic conditions, and lack of a specific diagnostic test. A delay in PsA diagnosis and treatment, even as short as 6 months, can lead to decreased quality of life, increased joint damage, and worse long-term physical function...
October 20, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30334147/secukinumab-is-superior-to-ustekinumab-in-clearing-skin-in-patients-with-moderate-to-severe-plaque-psoriasis-16-week-clarity-results
#5
Jerry Bagel, John Nia, Peter W Hashim, Manmath Patekar, Ana de Vera, Sophie Hugot, Kuan Sheng, Summer Xia, Isabelle Gilloteau, Elisa Muscianisi, Andrew Blauvelt, Mark Lebwohl
INTRODUCTION: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, has demonstrated superior efficacy to ustekinumab in the phase 3b CLEAR study of moderate to severe plaque psoriasis. Here, we report 16-week results from CLARITY, a second head-to-head trial comparing secukinumab with ustekinumab. METHODS: In the phase 3b CLARITY study, patients were randomized 1:1 to receive subcutaneous secukinumab 300 mg or ustekinumab per label. The co-primary objectives were to demonstrate the superiority of secukinumab over ustekinumab at Week 12 in relation to the proportion of patients with (1) 90% or more improvement from baseline Psoriasis Area and Severity Index (PASI 90) and (2) a score of 0/1 (clear/almost clear) on the modified Investigator's Global Assessment (IGA mod 2011 0/1)...
October 17, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30306395/the-comorbidity-burden-of-hidradenitis-suppurativa-in-the-united-states-a-claims-data-analysis
#6
Alexandra B Kimball, Murali Sundaram, Genevieve Gauthier, Annie Guérin, Irina Pivneva, Rakesh Singh, Arijit Ganguli
INTRODUCTION: Prior studies have reported that hidradenitis suppurativa (HS) is accompanied by a myriad of physical and mental conditions. However, given the small sample sizes and the limited number of pre-selected comorbidities, these studies do not provide a complete picture of the comorbidity burden of HS in the USA. Moreover, the relationship between HS severity and comorbidity burden has yet to be characterized. Using a large US claims database, we estimated the comorbidity burden associated with HS, stratified by disease severity...
October 10, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30255281/a-case-of-nail-psoriasis-successfully-treated-with-intralesional-methotrexate
#7
Sana Mokni, Khaoula Ameur, Najet Ghariani, Badreddine Sriha, Colandane Belajouza, Mohamed Denguezli, Rafiaa Nouira
Psoriasis is a chronic inflammatory disease affecting the skin, nails, and joints. About 61% of psoriatic patients have nail involvement that can cause a significant social problem. Treating nail psoriasis is challenging but can improve the health outcomes and quality of life of patients. Treatment options available for nail psoriasis including topical therapy, intralesional injections, and systemic and biologic agents have various side effects and some benefits. Management is currently inconclusive. Intralesional injection of methotrexate in nail psoriasis was previously documented in few cases...
September 25, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30232682/disease-burden-and-treatment-patterns-of-psoriasis-in-russia-a-real-world-patient-and-dermatologist-survey
#8
Alexey A Kubanov, Andrey L Bakulev, Tatiana V Fitileva, Evgenia Novoderezhkina, Isabelle Gilloteau, Haijun Tian, Tanya Howe, Guilhem Pietri
INTRODUCTION: Data regarding disease burden and quality of life (QoL) for patients with psoriasis from Russia are limited. The objective of this study was to describe the demographic and clinical characteristics, comorbidities, and treatment patterns of systemic therapy eligible psoriasis patients in Russia in order to assess the impact of psoriasis on the QoL and work productivity of the patients and to evaluate patient/dermatologist concordance on disease severity, signs/symptoms, and satisfaction with psoriasis treatment...
September 19, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30229459/acral-melanoma-a-patient-s-experience-and-physician-s-commentary
#9
Elizabeth Greenwald, Anonymous Patient, David Polsky, Tracey N Liebman
This article, co-authored by a patient diagnosed with acral melanoma, discusses the patient's experience of being diagnosed with and treated with surgery for this disease. The physician discusses the epidemiology, genetics, diagnosis, treatment, and prognosis of acral melanoma. Follow-up care plans are also discussed.
September 18, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30203232/topical-selenium-sulfide-for-the-treatment-of-hyperkeratosis
#10
Philip R Cohen, Caesar A Anderson
Hyperkeratosis presents as thickened skin. It can be congenital or acquired. Typically, it affects the palms and soles; the distribution of epidermal involvement is either diffuse, focal, or punctate. Microscopically, the pathologic signature of hyperkeratosis is marked orthokeratosis of the stratum corneum. Topical treatments provide the mainstay of therapy for hyperkeratosis. These include keratolytics (such as urea, salicylic acid, and lactic acid) and retinoids; physical debridement, topical corticosteroids, and phototherapy (using topical psoralen and ultraviolet A phototherapy) are other local therapeutic modalities...
September 10, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30182182/treatment-of-atopic-dermatitis-with-biologic-drugs
#11
REVIEW
Gabriella Fabbrocini, Maddalena Napolitano, Matteo Megna, Nicola Balato, Cataldo Patruno
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease which predominately affects children and usually clears up during infancy or childhood. However, AD may persist with a chronic relapsing course until adulthood or develop at a later age. AD treatment can often be complicated. Treating moderate-to-severe AD can be challenging: only a few therapeutic options are available, with cyclosporine being the only approved and labeled systemic drug. In the last few years, advances in the knowledge of AD pathogenesis have been made that can provide the basis for developing new topical and systemic drugs...
September 4, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30145740/treatment-of-genital-psoriasis-a-systematic-review
#12
REVIEW
Kristen M Beck, Eric J Yang, Isabelle M Sanchez, Wilson Liao
Genital psoriasis affects approximately 63% of psoriasis patients at least once in their lifetime. More than any other area on the body, genital lesions significantly impair patients' psychologic well-being and quality of life. We aimed to systematically review the published evidence on the safety, efficacy, and tolerability of treatments of genital psoriasis and synthesize the available clinical data. A total of 1 randomized controlled trial, 11 open-label studies, and 26 case reports were included in our analysis, representing a total of 458 patients, of which 332 were adults and 126 were children...
August 25, 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30099694/trichotillomania-and-trichophagia-modern-diagnostic-and-therapeutic-methods
#13
REVIEW
Hanna Cisoń, Aleksandra Kuś, Ewa Popowicz, Marta Szyca, Adam Reich
Trichotillomania is a chronic, mental disease of impulse control, characterized by repetitive, compulsive, and self-induced hair pulling. It can occur at any age but is observed more often in adolescents, with a strong predominance in females. Diagnosis of trichotillomania may be difficult, and its effective treatment challenging. The aim of this study is to critically review current literature regarding diagnostic procedures and treatment of trichotillomania, including psychotherapy, N-acetylcysteine, naltrexone, topiramate, atypical neuroleptics, and selective serotonin-reuptake inhibitors...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30097899/a-rapid-and-cost-effective-device-for-testing-minimal-erythema-dose
#14
Leah Conant, Kristen M Beck, Wilson Liao
INTRODUCTION: We describe a novel device for rapid and economical minimal erythema dose testing in patients undergoing ultraviolet (UV) light phototherapy for treatment of skin diseases. METHODS: A minimal erythema testing device was designed and created using transparent plastic sheeting and printed patterns with increasing ink density, allowing for graded UV transmission of 100%, 80%, 60%, 40%, 20%, and 10% energy through six 10-mm square apertures. The plastic sheet was placed in a UV-impenetrable and Velcro-fitted adjustable sleeve, designed to fit easily onto a patient's arm...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30054800/a-single-arm-open-label-phase-iv-study-to-evaluate-the-efficacy-of-a-topical-formulation-for-hyperkeratotic-actinic-keratosis-lesions
#15
Maria Pia De Padova, Barbara Marzani, Daniela Pinto, Fabio Rinaldi
INTRODUCTION: Actinic keratosis (AKs) are epidermal lesions that commonly occur in skin exposed to chronic cumulative UV irradiation. Untreated AK lesions can advance to squamous cell carcinoma. Current treatments of AK have many shortcomings; for instance, not all treatments can be used for the hyperkeratotic form of AK. The aim of this study was to test the efficacy and tolerability of a topical product containing 2,4,6-octatrienoic acid and urea for the treatment of hyperkeratotic AK lesions...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30051298/daily-application-of-an-aqueous-acidifying-peelable-nail-polish-versus-weekly-amorolfine-for-topical-onychomycosis-treatment-a-prospective-randomized-blinded-trial
#16
Frank Eertmans, Nejib Doss, Bart Rossel, Els Adriaens
INTRODUCTION: Onychomycosis is a fungal nail infection, frequently caused by dermatophytes, which occurs in 2-14% of Western adults. The present study was set up to evaluate the efficacy and safety of a water-based, peelable nail polish (daily application), which acidifies the nail environment, versus a 5% amorolfine nail lacquer (weekly application) for topical treatment of mild-to-moderate onychomycosis. METHODS: One hundred two adults were randomized in this open, prospective, blinded trial...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/30051297/topical-application-of-5-fluorouracil-associated-with-distant-seborrheic-dermatitis-like-eruption-case-report-and-review-of-seborrheic-dermatitis-cutaneous-reactions-after-systemic-or-topical-treatment-with-5-fluorouracil
#17
Tyler Werbel, Philip R Cohen
INTRODUCTION: 5-Fluorouracil is a fluoropyrimidine antineoplastic medication that is used to topically treat actinic keratoses. Although local adverse effects to the drug are common and anticipated, distant skin reactions are rare and unexpected. In this case report, we describe a patient who developed seborrheic dermatitis-like eruption at a distant site after topical application of 5-fluorouracil to his arms. CASE REPORT: A 63-year-old man with actinic keratoses on his arms developed a facial seborrheic dermatitis-like reaction after topically applying 5-fluorouracil 5% cream twice daily to actinic keratoses on his forearms for 7 days...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/29943217/topical-ivermectin-in-the-treatment-of-papulopustular-rosacea-a-systematic-review-of-evidence-and-clinical-guideline-recommendations
#18
REVIEW
Chiel Cristiano F Ebbelaar, Aalt W Venema, Maria R Van Dijk
INTRODUCTION: Rosacea is a chronic inflammatory skin disease with different phenotypes. There is accumulating evidence that the commensal Demodex mite is linked to papulopustular rosacea. Established treatment options, including topical metronidazole, azelaic acid, and tetracyclines, are thought to work through their anti-inflammatory effects. However, none of these therapies have been shown to be curative and are associated with frequent relapses. Therefore, new and improved treatment options are needed...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/29905913/development-of-low-cost-locally-sourced-two-component-compression-bandages-in-western-kenya
#19
Aileen Y Chang, Edith C Tonui, Douglas Momanyi, Alex R Mills, Paul Wasike, Rakhi Karwa, Toby A Maurer, Sonak D Pastakia
INTRODUCTION: Compression therapy is well-established standard of care for chronic leg ulcers from venous disease and lymphedema. Chronic leg ulcers and lymphedema have a significant impact on quality of life, driven by pain, foul odor, and restricted mobility. Provision of layered compression therapy in resource-limited settings, as in Western Kenya and other regions of sub-Saharan Africa, is a major challenge due to several barriers: availability, affordability, and access to healthcare facilities...
September 2018: Dermatology and Therapy
https://www.readbyqxmd.com/read/29860652/basal-cell-carcinoma-a-patient-and-physician-s-experience
#20
Barbara J Cohen, Eliahou S Cohen, Philip R Cohen
In this article, the first coauthor, a patient with a basal cell carcinoma on her upper lip, discusses her experience with Mohs micrographic surgery for the treatment of the skin cancer. The second coauthor, who is the patient's physician (a dermatologist who shares her last name but is not a relative), diagnosed her skin cancer and referred her for Mohs surgery. The third coauthor, who is the patient's son and not only a dermatologist, but also a dermatopathologist and a Mohs surgeon (and also shares her last name), summarizes the presentation and treatment of the basal cell carcinoma...
September 2018: Dermatology and Therapy
journal
journal
44143
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"